Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Biomarkers
Filter     Order     Display # 
Date Item Title Hits
18 Feb 2010 Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping 207
17 Feb 2010 Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation 101
05 Feb 2010 QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients 108
18 Jan 2010 AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments 175
12 Jan 2010 Kinaxo Extends its Collaboration with Roche 62
30 Nov 2009 Bayer Starts Phase III Trial with Florbetaben 97
29 Nov 2009 WILEX AG receives preliminary results of the phase III trial with the diagnostic REDECTANE 321
30 Oct 2009 Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology 306
22 Oct 2009 GE and Lilly Achieve Significant Advancement in Cancer Research 241
11 Aug 2009 Dako enters collaboration with Genentech on diagnostic tests for patients with stomach cancer 610
14 Jul 2009 Abbott and GSK to Collaborate on Molecular Diagnostic Test to Select Candidate Patients for Future Cancer Immunotherapy 374
29 May 2009 Boehringer Ingelheim and DxS sign an agreement for a companion diagnostic to identify EGFR mutations in patients with lung cancer 437
26 May 2009 KineMed Enters Into Collaboration With Bristol-Myers Squibb 286
21 May 2009 Almac Announces Collaboration With Pfizer and The PETACC3 Translational Research Working Party, Focused on Molecular Subtyping and Biomarker Identification in Colorectal Cancer 211
25 Nov 2008 Dako enters new collaboration with Genentech on a companion diagnostic for a targeted cancer therapy 7724
13 Apr 2008 Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 1818
19 Mar 2008 Vermillion Announces Positive Results From Clinical Trial of Ovarian Tumor Triage Test; Study Meets Primary Endpoints 1087
16 Nov 2007 The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma 1182
15 Oct 2007 Celera and Collaborators Identify a Five-gene Genetic Risk Score(TM) that Predicts Risk of Coronary Heart Disease 1276
02 Aug 2007 GTC Biotherapeutics and LFB Biotechnologies developing CD20 Antibody 2167
16 Jul 2007 PreMD Signs Marketing and Distribution Agreement with AstraZeneca 1402
28 May 2007 Miraculins Announces Positive Final Results in Pivotal Prostate Cancer Biomarker Study 1703
23 May 2007 Organon and Philips team up to study drug effects at the molecular level 2055
12 Apr 2007 Anika Therapeutics Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by Galderma 1756
19 Mar 2007 Miraculins announces positive results in pivotal prostate cancer biomarker study 1760
20 Oct 2006 New antibody based diagnostic imaging agent demon-strates 100 % positive predictive accuracy in feasibility study 2260
16 Oct 2006 Ciphergen Presents Data at IGCS Supporting Use of Protein Biomarkers to Discriminate Malignant From Benign Pelvic Disease 2111
13 Oct 2006 EDP Biotech Debuts CA1-18 Tumor Marker Assay for Early Stage Colorectal Cancer 2537
02 Oct 2006 Serum HER-2/neu Change Predicts Clinical Outcome to Trastuzumab-Based Therapy 2264
19 Sep 2006 Independent Analysis Of Eortc Trial Confirms Survival Impact Of Biomarker Identified In Phase 3 Trial Of Genasense(R) In Melanoma 2258
 
<< Start < Prev 1 2 3 4 Next > End >>
Results 1 - 30 of 94

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Biologic and Immune Therapy of S. aureus Infections

Order Now

Recommended Report

Oncology Market Leaders
Order Now

Subscribe La Merie Biologics